Megadeals in Healthcare: A 2025 Mid-Year Review and Outlook
Healthcare megadeals, defined as transactions valued at $1 billion or more, slowed notably in the first half of 2025, according to data captured in the LevinPro database. There were 18 megadeals announced during the first half of 2025, a 33% decline from the 27 deals announced during the same period of 2024. The decline marks the lowest mid-year tally since 2020 and continues a downward trend from the 30 megadeals announced in the first half of 2022 and 19 in the first half of 2023. While the billion-dollar threshold was still crossed multiple times across the Biotechnology, Pharmaceutical, eHealth, Medical Devices and more sectors, the pace of activity suggests growing caution among... Read More »
Guardian Pharmacy Services Strengthens Pacific Northwest Presence With Acquisition
Guardian Pharmacy Services, Inc. announced on August 4 its acquisition of Managed Healthcare Pharmacy in Eugene, Oregon. Established in 1991, Managed Healthcare Pharmacy is one of Oregon’s largest long-term care (LTC) pharmacies, serving LTC communities across both Oregon and Washington. The pharmacy serves residents in assisted living and behavioral health communities, as well as individuals with intellectual and developmental disabilities. Founded in 2004 and headquartered in Atlanta, Georgia, Guardian is one of the nation’s largest LTC pharmacy companies. Guardian’s pharmacies provide client services and resident care to LTC communities, including assisted living and skilled... Read More »
Nucleus Network Acquires Hammersmith Medicines Research
On August 4, Nucleus Network announced the acquisition of Hammersmith Medicines Research (HMR) for an undisclosed price. HMR specializes in early clinical trials for pharmaceutical and biotechnology companies worldwide. Founded in 1993, HMR is now the biggest contract research organization (CRO) of its kind in the United Kingdom and one of the biggest in Europe. Melbourne-based Nucleus Network is the only early-phase clinical research provider with a global footprint, operating dedicated Phase I facilities in Australia, the United States and the United Kingdom. “We are deeply honored by the trust Dr Boyce has placed in us to carry forward HMR’s legacy,” said Teena Pisarev, Chief Executive... Read More »
Brightstar Capital Partners Acquires Analyte Health
New York City-based Brightstar Capital Partners announced on August 4 that it acquired Analyte Health. Analyte Health is a leading national company empowering patients to acquire and understand healthcare diagnostic information. By combining a national network of patient service diagnostic centers, a family of online digital assets and a national telehealth footprint, Analyte Health has delivered more than 2.2 million test results since its inception in 2007. Brightstar Capital Partners is a middle market private equity firm with more than $4 billion assets under management that is focused on investing in business services, industrials, consumer and government services and... Read More »
Audax Private Equity and Parthenon Capital Acquire Elevate Patient Financial Solutions
Audax Private Equity announced on August 4 that, alongside Parthenon Capital Partners, it has acquired Elevate Patient Financial Solutions (ElevatePFS). ElevatePFS delivers revenue cycle management (RCM) solutions to hospitals, health systems and health providers nationwide. ElevatePFS was backed by private equity firm Frazier Healthcare Partners. During its ownership, Frazier partnered with ElevatePFS’s management team to accelerate organic growth through significant investments in talent, commercial infrastructure and technology. Additionally, Frazier supported seven strategic add-on acquisitions that expanded Elevate’s solution suite and transformed ElevatePFS into a... Read More »
Generational Group Advises Excel Pediatric Therapy in its Sale to an Individual Investor
Generational Group announced on July 29 the sale of The Rockwall Center of Sensory Integration, Inc., doing business as Excel Pediatric Therapy, to an undisclosed individual investor. The acquisition closed June 27, 2025. Financial terms were not disclosed. Excel Pediatric Therapy offers comprehensive physical, occupational and speech therapy for children from birth up to seventeen years old. Based in Rockwall, Texas, the clinic treats a range of neurological, orthopedic and developmental conditions, such as sensory processing disorders, autism, ADHD, cerebral palsy and feeding issues. Generational Group is a leading mergers and acquisitions advisory firm for privately held businesses. It... Read More »
LucyRx Acquires CerpassRx in First PBM Deal of 2025
According to a July 31 announcement, LucyRx has signed a definitive agreement to bring CerpassRx under its umbrella. The transaction is subject to regulatory approvals and customary closing conditions and is expected to close in Q3 2025. CerpassRx is a leading, full-service, pharmacy benefit manager (PBM) based in the Dallas-Fort Worth, Texas area. Its services include prescription optimization, flexible formulary designs, personalized member support and mail and specialty pharmacy programs. CerpassRx is a division of Nomi Health, a direct healthcare company. LucyRx is a PBM known for simplifying and improving access to prescription care. Partnering with more than 60,000 pharmacies, LucyRx... Read More »
Integrated Diagnostic Services Acquires Community of Nevada Diagnostics
Integrated Diagnostic Services (IDS), based in Burbank, California, announced that it acquired Community of Nevada Diagnostics. Community of Nevada Diagnostics is a leading provider of mobile imaging services in Nevada. It delivers mobile X-ray, ultrasound, EKG and echocardiogram services to home health and hospice agencies as well as skilled nursing and long-term care facilities throughout the Las Vegas and Reno markets. Backed by private equity group HCAP Partners, IDS is a network of mobile diagnostic providers. The company was established in 2025. Founded to offer a more responsive and cost-effective alternative to hospital-based diagnostics, IDS improves access to timely... Read More »
IVI RMA Acquires ART Fertility Clinics Operations
On July 30, IVI RMA announced its second transaction of the year with the acquisition of ART Fertility Clinics’ operations in the United Arab Emirates and Saudi Arabia. ART Fertility Clinics is based in Abu Dhabi and is a leading provider of fertility services across the Middle East and India. The scope of the transaction includes the three clinics. The assets are being acquired from Gulf Capital, an alternative investment firm focused on the Gulf Cooperation Council (GCC) region and the majority shareholder in ART Fertility Clinics. IVI RMA is one of the world’s leading reproductive medicine groups. The company operates more than 195 clinical offices and more than... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
